Poster
Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples
November 27, 2024
Biologic drugs are used to treat auto-immune inflammatory responses associated with IBD. The body may develop anti-drug antibodies against these drugs over time and can be mitigated by ensuring an optimal dosage in patients. This poster details a review of specimens submitted to Labcorp for these drugs and anti-drug antibodies.